D1 Medical Technology Company

Developer of organoid technology intended to support regeneration medicine and transplantation. The company develops organoids to improve the development of disease diagnosis and treatment, new drug screening, and tumor marker identification, providing accurate, efficient and high-quality organoid models for new drug development and personalized treatments.
Technology: Organoids
Industry: Providers/ R&D
Headquarters: Shanghai, China
Founded Date: 2019-01-01
Total Funding: 186000000
Register and Claim Ownership